Rare diseases
Investigational molecules
Locations
14 Wiryeseongdae-Ro, 05545
Hanmi Pharm. Co. Ltd. is active in clinical research on congenital hyperinsulinism, with a focus on pediatric patients affected by abnormal insulin regulation and recurrent hypoglycemia. Its work in this area centers on therapies intended to address the underlying metabolic instability associated with this rare endocrine condition.
The sponsor’s research interest in this field reflects a therapeutic emphasis on rare metabolic diseases requiring specialized clinical management.
Hanmi Pharm. Co. Ltd. runs clinical trials in conditions such as Short-bowel syndrome, Congenital hyperinsulinaemic hypoglycaemia, Hyperinsulinism, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Belgium
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
